S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
NYSE:BAX

Baxter International - BAX Stock Forecast, Price & News

$58.59
+0.68 (+1.17%)
(As of 08/5/2022 08:48 PM ET)
Add
Compare
Today's Range
$57.49
$58.61
50-Day Range
$57.91
$76.16
52-Week Range
$57.49
$89.70
Volume
2.45 million shs
Average Volume
3.18 million shs
Market Capitalization
$29.51 billion
P/E Ratio
29.30
Dividend Yield
1.98%
Price Target
$79.29

Baxter International MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.69 Rating Score
Upside/​Downside
35.3% Upside
$79.29 Price Target
Short Interest
Healthy
1.32% of Shares Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.95
Upright™ Environmental Score
News Sentiment
-0.15mentions of Baxter International in the last 14 days
Based on 18 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.15%
From $3.62 to $4.06 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.22 out of 5 stars

Medical Sector

13th out of 1,283 stocks

Surgical & Medical Instruments Industry

2nd out of 130 stocks

BAX stock logo

About Baxter International (NYSE:BAX) Stock

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Baxter International Stock Up 1.2 %

Shares of NYSE:BAX traded up $0.68 during midday trading on Friday, hitting $58.59. The stock had a trading volume of 2,448,400 shares, compared to its average volume of 3,262,792. Baxter International has a 12 month low of $57.49 and a 12 month high of $89.70. The company has a quick ratio of 1.33, a current ratio of 2.01 and a debt-to-equity ratio of 1.83. The business's 50-day simple moving average is $66.20 and its 200-day simple moving average is $74.61. The company has a market cap of $29.51 billion, a P/E ratio of 29.30, a PEG ratio of 1.60 and a beta of 0.60.

Baxter International (NYSE:BAX - Get Rating) last posted its earnings results on Thursday, July 28th. The medical instruments supplier reported $0.87 earnings per share for the quarter, hitting analysts' consensus estimates of $0.87. The company had revenue of $3.75 billion during the quarter, compared to the consensus estimate of $3.88 billion. Baxter International had a return on equity of 21.75% and a net margin of 7.12%. The company's revenue was up 20.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.80 earnings per share. On average, sell-side analysts forecast that Baxter International will post 3.62 earnings per share for the current fiscal year.

Baxter International Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 3rd. Shareholders of record on Friday, September 2nd will be paid a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 1.98%. The ex-dividend date of this dividend is Thursday, September 1st. Baxter International's payout ratio is 58.00%.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Wells Fargo & Company lowered shares of Baxter International from an "overweight" rating to an "equal weight" rating and set a $71.00 price objective for the company. in a research report on Friday, June 24th. The Goldman Sachs Group reaffirmed a "sell" rating and set a $60.00 price target (down previously from $70.00) on shares of Baxter International in a research report on Wednesday. Deutsche Bank Aktiengesellschaft dropped their price target on Baxter International from $99.00 to $69.00 in a research note on Friday, July 29th. Raymond James lowered their price target on Baxter International from $96.00 to $85.00 in a research report on Friday, April 29th. Finally, Morgan Stanley dropped their price objective on Baxter International from $86.00 to $72.00 and set an "overweight" rating on the stock in a research report on Friday, July 29th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and ten have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $79.29.

Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Stock News Headlines

Baxter Reports Second-Quarter 2022 Results
See More Headlines
Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Company Calendar

Ex-Dividend for 7/1 Dividend
6/02/2022
Dividend Payable
7/01/2022
Last Earnings
7/28/2022
Today
8/08/2022
Ex-Dividend for 10/3 Dividend
9/01/2022
Dividend Payable
10/03/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
07181310
Employees
60,000
Year Founded
1931

Price Target and Rating

Average Stock Price Forecast
$79.29
High Stock Price Forecast
$100.00
Low Stock Price Forecast
$60.00
Forecasted Upside/Downside
+35.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.69
Research Coverage
13 Analysts

Profitability

Net Income
$1.28 billion
Pretax Margin
7.91%

Debt

Sales & Book Value

Annual Sales
$12.78 billion
Cash Flow
$5.45 per share
Book Value
$18.22 per share

Miscellaneous

Free Float
502,553,000
Market Cap
$29.51 billion
Optionable
Optionable
Beta
0.61

Social Links















BAX Stock - Frequently Asked Questions

Should I buy or sell Baxter International stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Baxter International stock.
View analyst ratings for Baxter International
or view top-rated stocks.

What is Baxter International's stock price forecast for 2022?

13 Wall Street analysts have issued twelve-month price targets for Baxter International's shares. Their BAX stock forecasts range from $60.00 to $100.00. On average, they expect Baxter International's stock price to reach $79.29 in the next twelve months. This suggests a possible upside of 35.3% from the stock's current price.
View analysts' price targets for Baxter International
or view top-rated stocks among Wall Street analysts.

How has Baxter International's stock price performed in 2022?

Baxter International's stock was trading at $85.84 at the start of the year. Since then, BAX stock has decreased by 31.7% and is now trading at $58.59.
View the best growth stocks for 2022 here
.

When is Baxter International's next earnings date?

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our earnings forecast for Baxter International
.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) announced its earnings results on Thursday, July, 28th. The medical instruments supplier reported $0.87 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.87. The medical instruments supplier had revenue of $3.75 billion for the quarter, compared to analysts' expectations of $3.88 billion. Baxter International had a trailing twelve-month return on equity of 21.75% and a net margin of 7.12%. The company's revenue for the quarter was up 20.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.80 earnings per share.
Read Baxter International's conference call transcript
.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Tuesday, July 12th. Investors of record on Friday, September 2nd will be given a dividend of $0.29 per share on Monday, October 3rd. This represents a $1.16 annualized dividend and a yield of 1.98%. The ex-dividend date is Thursday, September 1st.
View Baxter International's dividend history
.

Is Baxter International a good dividend stock?

Baxter International(NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 1.98%. Baxter International has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Baxter International is 58.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Baxter International will have a dividend payout ratio of 28.57% next year. This indicates that Baxter International will be able to sustain or increase its dividend.
View Baxter International's dividend history.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International updated its FY 2022 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of $3.60-$3.70 for the period, compared to the consensus estimate of $4.13. The company issued revenue guidance of -.

What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International CEO José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among Baxter International's employees.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Honeywell International (HON), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by many different retail and institutional investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.30%), Cooke & Bieler LP (0.26%), Pensioenfonds Rail & OV (0.24%), Bartlett & Co. LLC (0.12%), New York State Teachers Retirement System (0.11%) and Tobam (0.06%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Brian Stevens, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth and Sean Martin.
View institutional ownership trends for Baxter International
.

How do I buy shares of Baxter International?

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $58.59.

How much money does Baxter International make?

Baxter International (NYSE:BAX) has a market capitalization of $29.51 billion and generates $12.78 billion in revenue each year. The medical instruments supplier earns $1.28 billion in net income (profit) each year or $2.00 on an earnings per share basis.

How many employees does Baxter International have?

Baxter International employs 60,000 workers across the globe.

Does Baxter International have any subsidiaries?

The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..
Read More

When was Baxter International founded?

Baxter International was founded in 1931.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The official website for Baxter International is www.baxter.com. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at global_corp_investor_relations@baxter.com, or via fax at 224-948-1813.

This page (NYSE:BAX) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.